• ABOUT GBR

  • AEROSPACE

  • CHEMICALS

  • MINING

  • PHARMACEUTICALS

INTERVIEWS MORE INTERVIEWS

"Based on our in vivo data for our lead CEACAM1/5 antibody YB-200 we have obtained orphan drug status from FDA for the treatment of liver cancer."
"We produce approximately 7% of the global vanadium supply, and on the titanium side, we are expected to produce about two thirds of the Brazilian demand for titanium pigment once the project reaches full capacity."
"Ontario has one of the highest densities of expertise in underground mining out of any of the jurisdictions we work in."
"For the next 20 years, there will be lots of exploration and development in a region where there are few roads and limited sea access. So, aviation will play a crucial role in the green transition."

ARTICLES

Protecting Supply Chains and Prosperity: The Case for Reducing US Dependency on Foreign Critical Minerals

October 12, 2022
Expert Opinion Article by Eric Mears, Vice President, Haley & Aldrich

Arizona Copper Production: Securing a Domestic Supply Chain

October 10, 2022
Arizona, leading the charge towards the green transition

Driving Change: The responsible sourcing of cobalt and other key materials for the EV industry

May 23, 2022
“The low carbon economy will likely require US$50 trillion of investment over the next three decades, making it the biggest purchase order in history.”

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.

PARTNER EVENTS